These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 14919453)

  • 1. [Colorimetric determination of iron in colloid iron-saccharate solutions].
    OVERKAMP H
    Munch Med Wochenschr; 1952 Feb; 94(5):220-21. PubMed ID: 14919453
    [No Abstract]   [Full Text] [Related]  

  • 2. [Constitution of ferri-3-saccharate].
    BERSIN T
    Pharm Acta Helv; 1951 Dec; 26(12):407-8. PubMed ID: 14941666
    [No Abstract]   [Full Text] [Related]  

  • 3. Physicochemical Characterization of Iron Carbohydrate Colloid Drug Products.
    Zou P; Tyner K; Raw A; Lee S
    AAPS J; 2017 Sep; 19(5):1359-1376. PubMed ID: 28762128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Iron saccharate tolerance tests].
    STILLE G
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1953; 218(1-2):138-9. PubMed ID: 13087338
    [No Abstract]   [Full Text] [Related]  

  • 5. [Intravenous ferric saccharate therapy of iron deficiency anemia in gynecology].
    STRAHM A; WALTER F
    Zentralbl Gynakol; 1951; 73(11):1011-5. PubMed ID: 14867649
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cooley's syndrome in the adult: treatment with intravenous iron saccharate].
    MEGASSINI VE; MHANI NO
    Sem Med; 1950 May; 57(18):730-3. PubMed ID: 15418306
    [No Abstract]   [Full Text] [Related]  

  • 7. Intravenous iron therapy with saccharated iron oxide.
    DESHMUKH PL
    Ind Med Gaz; 1952 Jul; 87(7):287-92. PubMed ID: 12990194
    [No Abstract]   [Full Text] [Related]  

  • 8. The hematologic response of the pregnant woman to intravenous saccharated iron oxide.
    NICHOLSON DB; ASSALI NS
    Surg Gynecol Obstet; 1952 May; 94(5):513-8. PubMed ID: 14922134
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of experimental block of reticuloendothelial system with trypan blue and iron saccharate on anoxemic resistance in rat].
    ARTETA JL; PUCHOL JR
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1954; 221(5):387-92. PubMed ID: 13185317
    [No Abstract]   [Full Text] [Related]  

  • 10. Experimental investigations on saccharated iron oxide.
    HAGBERG B; VAHLQUIST B; DICKIE W
    Acta Soc Med Ups; 1953; 58(1-2):73-82. PubMed ID: 13057653
    [No Abstract]   [Full Text] [Related]  

  • 11. [On the problem of the effect of feeding of iron saccharate on the mutation rate induced by roentgen rays in Drosophila melanogaster].
    TRAUT H
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1960; 91():325-32. PubMed ID: 13777913
    [No Abstract]   [Full Text] [Related]  

  • 12. Histological appearances following intravenous saccharated iron oxide, and the factors governing precipitation of the compound in vivo.
    NISSIM JA
    Guys Hosp Rep; 1953; 102(2):164-79. PubMed ID: 13044079
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hematological response of pregnant to saccharated iron oxide].
    NICHOLSON DB; ASSALI NS
    Dia Med; 1952 Aug; 24(55):1431-4. PubMed ID: 13020745
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of i.v. iron saccharate in haemodialysis patients not responding to oral iron and erythropoietin.
    al-Hawas F; Abdalla AH; Popovich W; Mousa DH; al-Sulaiman MH; al-Khader AA
    Nephrol Dial Transplant; 1997 Dec; 12(12):2801-2. PubMed ID: 9430909
    [No Abstract]   [Full Text] [Related]  

  • 15. The immediate hematologic effects of intravenous saccharated iron oxide.
    WHITE LP; BIERMAN HR; KELLY KH; BYRON RL
    Blood; 1952 Sep; 7(9):897-903. PubMed ID: 14953947
    [No Abstract]   [Full Text] [Related]  

  • 16. [Protective effect of the lysosomotrophic preparation rheopolyglucin in treating iron-deficient anemia with iron saccharate].
    Ageeva TA; Shkurupiĭ VA
    Biull Eksp Biol Med; 1994 Jul; 118(7):40-3. PubMed ID: 7522618
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmaceutical characterization and thermodynamic stability assessment of a colloidal iron drug product: iron sucrose.
    Shah RB; Yang Y; Khan MA; Raw A; Yu LX; Faustino PJ
    Int J Pharm; 2014 Apr; 464(1-2):46-52. PubMed ID: 24440404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous ferric saccharate as an iron supplement in dialysis patients.
    Silverberg DS; Blum M; Peer G; Kaplan E; Iaina A
    Nephron; 1996; 72(3):413-7. PubMed ID: 8852489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The behavior of iron saccharates in the body and its therapeutic significance].
    PRIBILLA W
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1953; 217(5):508-38. PubMed ID: 13087302
    [No Abstract]   [Full Text] [Related]  

  • 20. [Iron storage and metabolism in nacrophages and endothelial cells after intravenous administration of colloidal ferric saccharate in man].
    Düllmann J; Wulfhekel U; Hausmann K
    Verh Anat Ges; 1976; (70 Pt 2):971-6. PubMed ID: 1024396
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.